These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25622833)

  • 1. [Analysis of pathological characteristics of acute and chronic cerebral tumefactive demyelinating lesions].
    Sun C; Liu J; Gui Q; Lu D; Qi X
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(45):3557-61. PubMed ID: 25622833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
    Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
    Front Immunol; 2022; 13():986473. PubMed ID: 36059526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases].
    Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of tumefactive demyelinating lesions and glioma by clinical presentations and neuroimaging studies].
    Liu J; Qiao W; Zheng K; Zhao H; Qian H; Yao S; Duan F; Qiu F; Qi X
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(39):3047-51. PubMed ID: 25549675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumefactive demyelinating lesions: a clinicopathological correlative study.
    Neelima R; Krishnakumar K; Nair MD; Kesavadas C; Hingwala DR; Radhakrishnan VV; Nair SS
    Indian J Pathol Microbiol; 2012; 55(4):496-500. PubMed ID: 23455787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
    Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
    Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
    Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
    J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
    Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
    J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
    Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
    Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
    Sánchez P; Meca-Lallana V; Barbosa A; Manzanares R; Palmí I; Vivancos J
    J Neurol Sci; 2017 Oct; 381():32-38. PubMed ID: 28991707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelinating pseudotumor.
    Erana-Rojas IE; Barboza-Quintana A; Ayala AG; Fuller GN
    Ann Diagn Pathol; 2002 Oct; 6(5):265-71. PubMed ID: 12376918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumefactive Demyelinating Lesions and Pregnancy.
    Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
    Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic features of tumefactive demyelinating lesions in different clinical stages by contrast-enhanced magnetic resonance imaging].
    Song DD; Qi XK; Liu JG; Zhao HL; Wang QJ; Diao DW; Wang QQ
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(43):3513-3518. PubMed ID: 30481901
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
    Jain RS; Khan I; Kandelwal K; Desai T
    Clin Neurol Neurosurg; 2017 Nov; 162():91-94. PubMed ID: 28987645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
    Chew SH; Achmad Sankala HB; Chew E; Md Arif MHB; Mohd Zain NR; Hashim H; Koya Kutty SB; Chee YC; Mohd Saleh NB; Ong BH; Viswanathan S
    Mult Scler Relat Disord; 2023 Nov; 79():104992. PubMed ID: 37717306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinicopathological study of demyelination pseudotumors of the brain].
    Liu D; Yang C; Liu X; Cai K; Cui D; Man K
    Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):16-9. PubMed ID: 11955329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.